Skin biopsy specimens of three lesions on her back were consistent with cutaneous T-cell lymphoma (CTCL ... with desoximetasone 0.25% ointment b.i.d. and then clobetasol propionate 0.05% cream ...

High-potency Class I to II topicals are frequently used first line to suppress inflammation and symptoms of itching. These agents are often useful as therapy for stage IA disease, but are often ...

Liso-Cel is a type of CAR T-cell therapy — a revolutionary approach that uses a patient's own immune cells to fight cancer.

American Cancer Society. Key statistics for lymphoma of the skin. Lima M. Cutaneous primary B-cell lymphomas: From diagnosis to treatment. An Bras Dermatol. 2015;90(5):687-706. American Cancer Society ...

Secondary cutaneous involvement is uncommon ... for the clinician to investigate other signs and symptoms that allow for a better diagnostic approach. The first clinical sign of diffuse large B-cell ...

Follicular lymphoma -- typically a slow-growing or indolent form of non-Hodgkin lymphoma that arises from B lymphocytes -- accounts ... if the patient has clinical symptoms, "that is the number ...

When he was first diagnosed with mantle cell lymphoma in New York in 2005 ... give those patients "a ton of steroids" to treat those symptoms, and that can limit the effectiveness of the treatment ...

If you have symptoms that could point to skin cancer, see your healthcare provider right away. Hodgkin lymphoma and cutaneous (skin) T-cell lymphoma are cancers that originate in the white blood cells ...

This study presents a valuable finding on the direct cytotoxic effects of DuoHexaBody-CD37 in diffuse large B-cell lymphoma, mediated via SHP-1 activation and antibody clustering, independent of ...

Newer-generation Bruton's tyrosine kinase (BTK) inhibitors have found a place in the management of follicular lymphoma, a ...